MedPath

ATRACURIUM BESYLATE INJECTION

ATRACURIUM BESYLATE INJECTION

Discontinued
DIN Number

02229757

Drug Class

Human

Market Date

Feb 11, 1998

Company
HC

ABBOTT LABORATORIES, LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02229757
AIG Number0116898001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M03AC04 ATRACURIUM
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification12:20.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

ATRACURIUM BESYLATEActive
Strength: 10 MG / ML
Monograph: ATRACURIUM BESYLATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.